항암화학요법 유방암환자의 인지기능 증진 중재에 대한 논문 분석 = Literature Review of Cognitive Developmental Interventions on Patients with Breast Cancer undergoing Chemotherapy

다국어 초록 (Multilingual Abstract)

Purpose: The purpose of this study was to analyze the trend of cognitive developmental interventions on patients with breast cancer who underwent chemotherapy. Methods: The researcher searched databases and selected 17 literatures using chemotherapy, breast cancer, cognitive function and intervention as searching key words. Searched databases included Ovid, Pubmed, Proquest and Medline and data collection period was from January 2000 to May 2010. Results: Interventions for patients with breast cancer have been continuously developed and frequent research topics included breast cancer, chemotherapy, quality of life, and cognitive function. In terms of study design, four research articles were pre-experimental study designs, one was case study, and the rest of studies were non-equivalent pretest-posttest control group design. Effects of intervention were examined in only 5 studies among 17. The interventions were not found to have direct effects in cognitive improvement. Conclusion: It is needed to figure out the mechanism of cognitive deterioration of the patients with breast cancer who underwent chemotherapy. And nursing interventions needs to be developed in order to hold up the cognitive downhill and help their cognitive rehabilitation.

목차 (Table of Contents)

• 서론
• 연구 방법
• 연구 결과
• 논의
• 결론 및 제언
• 참고문헌

참고문헌 (Reference)

1 Bender CM, 6 : 238-242, 2008

2 Jansen SJT, "The impact of the percetption of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life" 91 : 56-61, 2004

3 Si JY, "The effects of chronic schizophrenia patients’ symptoms and cognitive functions on their social functions" Catholic University of Daegu 2009

4 Cahn-Weiner AD, "Results of a randomized placebo-controlled study of memory training for mildly impaired Alzheimer’s disease patients" 10 : 215-223, 2003

5 Schilder CM, "Neuropsychological functioning in postmeno: cross-sectional findings from the neuropsychological TEAM-side study. Pausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy" 48 : 76-85, 2009

6 Joyce A, "Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in woman with breast cancer undergoing adjuvant chemotherapy" 3 : 116-120, 2008

7 Kang JJ, "Effects of cognitive function enhancement program: focusing on working memory" Seoul National University 2008

8 Patrick G, "Effectiveness of he ISAAC cognitive prosthetic system for improving rehabilitation outcomes with neurofunctional impairment" 18 : 57-67, 2003

9 Jenkins V, "Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study" 13 : 61-66, 2004

10 Marino P, "Deterioration of quality of life high-risk breast cancer patients treated with high-dose chemotherapy: the PEGASE 01 quality of life study" 11 : 709-718, 2008

11 Ferguson RJ, "Cognitive-behavioral management of chemotherapy-related cognitive change" 16 : 772-777, 2007

12 Bell M, "Cognitive remediation of working memory deficits: durability of training effects in severely impaired and less severely impaired schizophrenia" 108 : 101-109, 2003

13 Bender CM, "Cognitive impairment associated with adjuvant therapy in women with breast cancer" 15 : 422-430, 2006

14 Mulrooney T, "Cognitive impairment after breast Cancer treatment" 12 : 678-680, 2008

15 Jim HS, "Cognitive functioning in breast cancer survivors: a controlled comparison" 115 : 1776-1786, 2009

16 Downie FP, "Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment" 15 : 921-930, 2006

17 Vetto IP, "Cognitive Dysfunction in Cancer Patients: An educational needs area improved by a single intervention" 22 : 197-201, 2007

18 Lemieux J, "Chemotherapy-induced alopecia effects on quality of life among women with breast cancer: a literature review" 17 : 317-328, 2008

19 Biegler KA, "Cancer, cognitive impairment, and meditation" 48 : 18-26, 2009

20 Vardy J, "Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop" 19 : 623-629, 2008

21 Freeman JR, "Assessing cognitive dysfunction in breast cancer: what are the tools" 3 : 91-99, 2002

22 Sarah E, "A group cognitive behaviour therapy programme with metastatic breast cancer patients" 8 : 295-305, 1999